Mölnlycke Health Care Recalls Hibiwash Batches
Summary
The Care Inspectorate has issued a notice regarding Mölnlycke Health Care's recall of specific batches of Hibiwash. This action is taken due to potential issues with the product, and further information is available via a link to the UK government's drug and device alerts.
What changed
Mölnlycke Health Care is recalling specific batches of its Hibiwash product. The Care Inspectorate has issued a notice to inform relevant parties about this recall. While the specific reason for the recall is not detailed in this announcement, it is categorized as a product safety issue.
Healthcare providers and potentially other entities that have procured these specific batches of Hibiwash should consult the provided UK government link for detailed information on the affected batches, the nature of the defect or risk, and instructions on how to proceed. This may include returning the product, discontinuing its use, and potentially reporting any adverse events.
What to do next
- Consult the UK government drug and device alerts for details on affected Hibiwash batches.
- Follow instructions provided in the drug and device alerts regarding the recall.
Source document (simplified)
Mölnlycke Health Care are recalling specific batches of Hibiwash - further information here.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Scotland Care Inspectorate News publishes new changes.